EPHB4 and cancer: Since RNA-seq data in our preclinical model displayed transcriptomic changes following EphB4 loss on the cancer cell particularly in pathways regulating angiogenesis, cell survival, and IFN-gamma related gene signatures, we expanded our analysis to the HNSCC TCGA datasets of interest.